Practice Tip: Use Visual Aids to Show the Seriousness of Glaucoma
“Glaucoma’s insidious nature of progression without early symptoms makes the stringent adherence of patients to their intraocular pressure-lowering drops crucial, writes Justin Holt, OD, in the March issue feature article “Achieving Patient Adherence to IOP-Lowering Drugs.” One way he says he has found success in increasing patient adherence is to use diagrams, eye models, and digital apps. See the latest issue of OM.

Alcon and World Council of Optometry Dry Eye Wheel Available in French
Alcon and the World Council of Optometry’s (WCO) Dry Eye Wheel is now accessible to the French-speaking optometry community at no cost via the WCO website. The Wheel, also available in English and Spanish, aids in the diagnosis and management of the chronic condition. In other news, the WCO will host its 6th World Congress of Optometry in partnership with the 11th Conference of the Saudi Society of Optometry, in Riyadh, Saudi Arabia, in November 2026. For more information, email enquires@worldoptometry.org or advocacy@sso.org.sa.

Avulux Added to Consortium for Technology & Innovation in Pediatrics Product Portfolio
Avulux, the maker of spectacle lenses for migraines announced that the Consortium for Technology & Innovation in Pediatrics (CTIP) has added the lenses into their product portfolio, according to a press release. CTIP connects clinicians, engineers, regulators, patients, and businesses, while providing portfolio companies with networking, financial support, and guidance on intellectual property, prototyping, testing, and clinical trials across its 25-organization network spanning 8 states.

Bausch + Lomb’s Dry Eye Drug Improves Signs and Symptoms Within First 2 Weeks of Use, Study Shows 
Bausch + Lomb’s Miebo, a drop for the treatment of the signs and symptoms of dry eye disease (DED), was shown to have significant and meaningful reductions in the severity and frequency of DED symptoms within the first 2 weeks of treatment, according to a study published in Ophthalmology and Therapy. The study was composed of 99 patients (85.9% female; age range 35 to 81 years). Its purpose was to evaluate patient-reported outcomes early in treatment. 

Bausch + Lomb Voluntarily Recalls Intraocular Lenses
Bausch + Lomb Corporation voluntarily recalled the intraocular lenses (IOL) on its enVista platform: enVista Aspire, enVista Envy, and certain enVista monofocal IOLs—according to a press release. The recall is in response to reports of toxic anterior segment syndrome in conjunction with the implantation of these IOLs. All impacted patients responded quickly to treatment, and none have required removal of their IOLs, Bausch + Lomb says. The company says it is looking into identifying a root cause.

CooperVision Hosts 2025 Student Leadership Society Summit
CooperVision recently conducted its 2025 Student Leadership Society Summit at its 3 major facilities in Rochester, New York. Specifically, on World Optometry Day, March 23, close to 50 members of CooperVision’s Student Contact Lens Leadership Society and Student Myopia Leadership Society participated in hands-on fitting workshops, among other activities. Additionally, participants received tours of the company’s manufacturing and global distribution facilities in Scottsville and West Henrietta, NY. For more information about these programs, click here.

Harrow’s Injectable Preservative-Free Synthetic Corticosteroid Gets Transitional Pass-Through Reimbursement Status
Harrow announced that the Centers for Medicare & Medicaid Services has approved its transitional pass-through application for the company’s injectable preservative-free synthetic corticosteroid Triesence. Specifically, starting April 1, and for the following 3 years, the injectable will be eligible for separate reimbursement outside of the surgical bundled payment in both the Ambulatory Surgery Center and Hospital Outpatient Department settings of care, according to a press release.

Optometry Marketing Services Launches Marketing Resource Center
Optometry Marketing Services (OMS) has launched a Marketing Resource Center to provide independent optometry practices with a free and downloadable 2025 Social Media Content Calendar, a Step-by-Step Marketing Plan, and a Specialty Eye Care Social Media Bundle. Additionally, OMS is offering complimentary 1:1 strategy sessions with digital marketing experts, according to a press release. Visit OMS’s resource center here.

Prevent Blindness Designates April as Women’s Eye Health and Safety Month
Prevent Blindness (PB) has declared April as Women’s Eye Health and Safety Month. In recognition of this, PB is offering free resources, including fact sheets, shareable social media graphics, web pages on a range of eye health issues that predominantly affect women, and 2 Focus on Eye Health Expert Series episodes: “Healthy Vision and Eye Safety Tips for Women,” and “Women’s Eye Health and Safety.” For more information on women’s eye health topics, visit preventblindness.org.  OM